This session will review specific conditions encountered for risk adjustment in clinical practice. The session will explore specific CMS visit requirements and documentation guidelines. The session will also identify quality reporting requirements and gap closure for the specific conditions.

This session will review specific conditions encountered for risk adjustment in clinical practice. The session will explore specific CMS visit requirements and documentation guidelines. The session will also identify quality reporting requirements and gap closure for the specific conditions.

Cardiac contractility modulation (CCM) therapy is a new innovation in the treatment of symptomatic chronic heart failure patients who have a reduced left ventricular ejection fraction, who are in normal sinus rhythm and not candidates for cardiac resynchronization therapy.

Speaker: David Bartlett, MD - AHN Cancer Institute Physician Chair No conflicts disclosed